Literature DB >> 19074165

Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.

E H Kang1, K C Moon, E Y Lee, Y J Lee, E B Lee, C Ahn, Y W Song.   

Abstract

The aim of the study is to characterize the expression pattern of galectin-3 (Gal-3) in renal tissues of patients with systemic lupus erythematosus (SLE) nephritis and to determine whether tissue and serum Gal-3 are associated with SLE nephritis. Gal-3 expressions were examined with immunohistochemistry in renal biopsy specimens of 88 patients with SLE nephritis and in five normal specimens. Activity and chronicity indexes and glomerular Gal-3 expressions were analysed in each specimen. Serum Gal-3 levels were measured using enzyme-linked immunosorbent assays in 20 patients with SLE, including 11 with nephritis, and in 50 healthy controls. Glomerular Gal-3 expression was observed in 81.8% (72/88) of patients with SLE nephritis but not in 5 controls. Gal-3 staining was attributed mainly to its cellular expression rather than its deposition, and Gal-3 expression levels were correlated with histologic activity indexes, anti-dsDNA titers, and complement 3 and 4 levels. Serum Gal-3 levels were higher in patients with SLE, particularly in those with nephritis, than in healthy controls, and correlated with anti-dsDNA titers. In conclusion, glomerular Gal-3 expression in renal tissue and serum Gal-3 levels were elevated in patients with SLE nephritis versus healthy controls; moreover, they reflected disease activity. These findings suggest that Gal-3 might contribute to the inflammatory process in SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19074165     DOI: 10.1177/0961203308094361

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  25 in total

1.  Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model.

Authors:  Amy G Clark; Melissa L Weston; Mary H Foster
Journal:  Glycobiology       Date:  2013-04-01       Impact factor: 4.313

2.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

Review 3.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

4.  Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.

Authors:  John T Schroeder; Anja P Bieneman
Journal:  J Immunol       Date:  2017-06-26       Impact factor: 5.422

5.  Galectin-3: a potential target for cancer prevention.

Authors:  Hafiz Ahmed; Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya
Journal:  Trends Carbohydr Res       Date:  2011

6.  Serum galectin-3 level in systemic sclerosis.

Authors:  Suleyman Serdar Koca; Fatma Akbas; Metin Ozgen; Servet Yolbas; Nevin Ilhan; Baris Gundogdu; Ahmet Isik
Journal:  Clin Rheumatol       Date:  2013-08-03       Impact factor: 2.980

7.  Galectin-8 in IgA nephritis: decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in non-IgA serum glycoproteins.

Authors:  Michael C Carlsson; Omran Bakoush; Lotta Tengroth; Ola Kilsgård; Johan Malmström; Thomas Hellmark; Mårten Segelmark; Hakon Leffler
Journal:  J Clin Immunol       Date:  2011-12-16       Impact factor: 8.317

8.  Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.

Authors:  Maria Kolatsi-Joannou; Karen L Price; Paul J Winyard; David A Long
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

9.  Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.

Authors:  Po-Ku Chen; Joung-Liang Lan; Ju-Pi Li; Ching-Kun Chang; Shih-Hsin Chang; Po-Hao Huang; Kai-Jieh Yeo; Der-Yuan Chen
Journal:  Clin Rheumatol       Date:  2020-01-20       Impact factor: 2.980

10.  Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

Authors:  Deepa M Gopal; Maya Kommineni; Nir Ayalon; Christian Koelbl; Rivka Ayalon; Andreia Biolo; Laura M Dember; Jill Downing; Deborah A Siwik; Chang-Seng Liang; Wilson S Colucci
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.